18320 Franjo Rd Palmetto Bay, FL 33157

Mon - Fri 8:00 AM - 5:00 PM Closed Sat & Sun

National Cancer Institute Supports Veteran Access to Clinical Trials

The U.S Department of Veteran Affairs (VA) announced a partnership with the National Cancer Institute today, which will provide veterans better access to cutting-edge cancer treatments and therapies.

The NCI and VA Interagency Group to Accelerate Trials Enrollment, also known as NAVIGATE, is launching at 12 VA sites. 

The VA will work with the NCI to build infrastructure at their sites, enabling more veterans to take part in cutting-edge clinical trials. Typically testing innovative experimental treatments like precision medicine therapies based on patients’ genetic profiles or immunotherapies that harness patient’s own immune systems for a cure.

The NAVIGATE network is a collaborative effort between the VA and NCI to enroll more veterans in cancer clinical trials. They do this by establishing best practices, sharing insights, and helping other medical centers across America bring awareness of enrollment opportunities for their veteran populations through national outreach efforts.

Despite having access to the same medical resources as non-Veteran patients, Veteran minority groups are often underrepresented in clinical trials. As a result of such obstacles, new treatments and therapies have not been made available to these populations and they may be less likely than other American citizens to receive them due to their ethnicity or veteran status.

Despite having access to the same medical resources as non-Veteran patients, Veteran minority groups are often underrepresented in clinical trials. As a result of such obstacles, new treatments and therapies have not been made available to these populations and they may be less likely than other American citizens to receive them due to their ethnicity or veteran status.

Veterans will also be able to enroll in clinical trials sponsored by the Community Oncology Research Program (CORP), which focuses on cancer prevention and symptom management.

The VA’s involvement in NAVIGATE is being managed through the Cooperative Studies Program (CSP) part of the VA’s Office of Research and Development. CSP has a long history of running impactful clinical trials focused on Veterans’ health needs, which makes them an excellent candidate for this project.

To learn more about CSP and VA Research, visit www.research.va.gov